ArticleCancer immunology, immunotherapy : CII2009

Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients.

Mary T Litzinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.